• 1
    Dowson JH. Pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD) in adults. Curr Psychiatry Rev 2006;2:317331.
  • 2
    American Psychiatric Association. Diagnostical and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
  • 3
    Dowson J, Bazanis E, Rogers R et al. Impulsivity in patients with borderline personality disorder. Compr Psychiatr 2004;45:2936.
  • 4
    Zepf FD, Stadler C, Demisch L, Schmitt M, Landgraf M, Poustka F. Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity disordered boys (ADHD): influence of rapid tryptophan depletion. Hum Psychopharmacol 2008;23:4351.
  • 5
    Retz W, Rosler M, Supprian T, Retz-Junginger P, Thome J. Dopamine D3 receptor gene polymorphism and violent behaviour: relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 2003;110:561572.
  • 6
    Hinshaw SP. Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages. Ann N Y Acad Sci 2003;1008:149159.
  • 7
    Muris P, Musters C. The validity of attention deficit hyperactivity and hyperkinetic disorder symptom domains in nonclinical Dutch children. J Clin Child Adolesc Psychol 2002;32:460466.
  • 8
    Coccaro EF, Siever LJ. The neuropsychopharmacology of personality disorders. In: BloomFE, KupferDJ, eds. Psychopharmacology: the fourth generation of progress. New York, NY: Raven, 1995:15671579.
  • 9
    Kaye R, Wolkenfeld F, Murrill LM. Profile of aggression among psychiatric patients. J Nerv Ment Dis 1988;176:539546.
  • 10
    Goodman G, Gerstadt C, Pfeffer CR, Stroh M, Valdez A. ADHD and aggression as correlates of suicidal behaviour in assaultive prepubertal psychiatric inpatients. Suicide Life Threat Behav 2008;38:4659.
  • 11
    Marks DJ, Mckay KE, Himelstein J, Walter KJ, Newcorn JH, Halperin JM. Predictors of physical aggression in children with attention-deficit/hyperactivity disorder. CNS Spectr 2000;5:5257.
  • 12
    Sinzig J, Dopfner M, Lehmkuhl G et al. Long-acting methylphenidate has an effect on aggressive behaviour in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:421432.
  • 13
    Banerjee S, Ayyash HF. Does atomoxetine increase the risk of aggression and hostility in children with attention deficit hyperactivity disorder (ADHD)? Arch Dis Child Educ Pract Ed 2008;93:131132.
  • 14
    Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. Ann N Y Acad Sci 2001;931:116.
  • 15
    Pappadopulos E, Woolston S, Chait A, Perkins M, Connor DF, Jensen PS. Pharmacotherapy of aggression in children and adolescents: efficacy and effect size. J Can Acad Child Adolesc Psychiatry 2006;15:2739.
  • 16
    Kronenberger WG, Giauque AL, Lafata DE, Bohnstedt BN, Maxey LE, Dunn DW. Quetiapine addition in methylphenidate treatment-resistant adolescents with co-morbid ADHD, conduct/oppositional defiant disorder, and aggression: a prospective, open-label study. J Child Adolesc Psychopharmacol 2007;17:334347.
  • 17
    Mckay KE, Halperin JM. ADHD, aggression and antisocial behaviour across the lifespan. Interactions with neurochemical and cognitive functions. Ann N Y Acad Sci 2001;931:8496.
  • 18
    Cabiya-Morales JJ, Padilla L, Sayers-Montalvo S, Pedrosa O, Perez-Pedrogo C, Manzano-Mojica J. Relationship between aggressive behaviour, depressed mood, and other disruptive behaviour in Puerto Rican children diagnosed with attention deficit and disruptive behaviour disorders. P R Health Sci J 2007;26:4349.
  • 19
    Murphy KR, Barkley RA, Bush T. Young adults with attention deficit hyperactivity disorder : subtype differences in comorbidity, educational and clinical history. J Nerv Ment Dis 2002;190:147157.
  • 20
    Cho SC, Kim JW, Choi HJ et al. Associations between symptoms of attention deficit hyperactivity disorder, depression, and suicide in Korean female adolescents. Depress Anxiety 2008;25:E142E146.
  • 21
    Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug Alcohol Depend 2004;73:8797.
  • 22
    James A, Lai FH, Dahl C. Attention deficit hyperactivity disorder and suicide : a review of possible associations. Acta Psychiatr Scand 2004;110:408415.
  • 23
    Harty SC, Miller CJ, Newcorn JH, Halperin JM. Adolescents with childhood ADHD and comorbid disruptive behaviour disorders: aggression, anger and hostility. Child Psychiatry Hum Dev 2009;40:8597.
  • 24
    Connor DF, Doerfler LA. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behaviour disorders? J Atten Disord 2008;12:126134.
  • 25
    Caspi A, Langley K, Milne B et al. A replicated molecular genetic basis for subtyping antisocial behaviour in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2008;65:203210.
  • 26
    Lahey BB, Loeber R, Burke JD, Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. J Consult Clin Psychol 2005;73:389399.
  • 27
    Satterfield J, Swanson J, Schell A, Lee F. Prediction of antisocial behaviour in attention-deficit hyperactivity disorder boys from aggression/defiance scores. J Am Acad Child Adolesc Psychiatry 1994;33:185190.
  • 28
    Nelson H. National Adult Reading Test Manuel. Windsor, UK: NFER-Nelson, 1982.
  • 29
    Barkley RA, Murphy KR. Attention deficit hyperactivity disorder. A clinical workbook, 2nd edn. New York: The Guilford Press, 1998.
  • 30
    Dowson JH. Characteristics of adults with attention-deficit/hyperactivity disorder and past conduct disorder. Acta Psychiatr Scand 2008;117:299305.
  • 31
    Dowson JH, Mclean A, Bazanis E et al. Impaired spatial working memory in adults with attention-deficit/hyperactivity disorder: comparison with performance in adults with borderline personality disorder and in control subjects. Acta Psychiatr Scand 2004;109:110.
  • 32
    Dowson JH. Associations of past oppositional defiant disorder in adults with attention-deficit/hyperactivity disorder. Open Psychiatry J 2008;2:2329.
  • 33
    Triolo SJ, Murphy KR. Attention-Deficit Scales for Adults (ADSA) manual for scoring and interpretation. New York: Brunner/Maze, 1996.
  • 34
    Derogatis LR. Brief Symptoms Inventory (BSI): administrative, scoring and procedural manual, 3rd edn. Minneapolis: National Computer Systems, 1993.
  • 35
    First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV Axis II Personality Disorder. Washington, DC: American Psychiatric Press, 1997.
  • 36
    First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. SCID-II Personality Questionnaire. Washington, DC: American Psychiatric Press, 1997.
  • 37
    Paris J. The development of impulsivity and suicidality in borderline personality disorder. Dev Psychopathol 2005;17:10911104.
  • 38
    Barker ED, Seguin JR, White HR et al. Developmental trajectories of male physical violence and theft: relations to neurocognitive performances. Arch Gen Psychiatry 2007;64:592599.
  • 39
    De Young CG, Peterson JB, Seguin JR et al. The dopamine D4 receptor gene and moderation of the association between externalizing behaviour and IQ. Arch Gen Psychiatry 2006;63:14101416.
  • 40
    Davids E, Gaspar M. Attention deficit hyperactivity disorder and borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:865977.
  • 41
    Golubchik P, Sever J, Zalsman G, Weizman A. Methylphenidate in the treatment of female adolescents with concurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol 2008;23:228231.
  • 42
    Hooberman D, Stern TA. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report. J Clin Psychiatry 1984;45:441442.
  • 43
    Nose M, Cipriani A, Biancosino B, Grassi L, Barbui C. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 2006;21:345353.
  • 44
    Bellino S, Paradiso E, Bogetto F. Efficacy and tolerability of pharmacotherapies for borderline personality disorder. CNS Drugs 2008;22:671692.
  • 45
    Lucas PB, Gardner DL, Wolkowitz OM, Cowdry RW. Dysphoria associated with methylphenidate infusion in borderline personality disorder. Am J Psychiatry 1987;144:15771579.
  • 46
    Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 1997;54:10731080.
  • 47
    Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997;20:427451.
  • 48
    Weller EB, Rowan A, Elia J, Weller RA. Aggressive behaviour in patients with attention-deficit/hyperactivity disorder, conduct disorder and pervasive developmental disorder. J Clin Psychiatry 1999;60(suppl. 15):511.
  • 49
    Amar MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol 2003;13:2940.
  • 50
    Parikh MS, Kolevzon A, Hollander E. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol 2008;18:157178.
  • 51
    Sokol MS, Gray NS, Goldstein A, Kaye WH. Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder. Int J Eat Disord 1999;25:233237.